Mus musculus breed:C57/BL6 Transcriptome or Gene expression. Mus musculus breed:C57/BL6
收藏NIAID Data Ecosystem2026-03-09 收录
官方服务：
资源简介：
To compare the mouse transcriptome responses across different Sm-p80 based vaccine formulations
应用场景：
创建时间：
2016-07-19
相关数据集
Fifteen years of Sm-p80-based vaccine trials in nonhuman primates: Antibodies from vaccinated baboons confer protection in vivo and in vitro from Schistosoma mansoni and identification of putative correlative markers of protection
Recent advances in systems biology have shifted vaccine development from a largely trial-and-error approach to an approach that promote rational design through the search for immune signatures and pre
NIAID Data Ecosystem50
Comparative transcriptomics between species attributes reactogenicity pathways induced by the capsular group B meningococcal vaccine, 4CMenB, to the membrane-bound endotoxin of its outer membrane vesicle component.. Comparative transcriptomics between species attributes reactogenicity pathways induced by the capsular group B meningococcal vaccine, 4CMenB, to the membrane-bound endotoxin of its outer membrane vesicle component.
Whole blood RNA-seq was leveraged to explore gene expression changes induced in mice 24 hours after immunisation with a second dose of a licensed vaccine against capsular group B meningococcus, one of
NIAID Data Ecosystem30
Cellular and Humoral Immune Responses and Protection against Schistosomes Induced by a Radiation-Attenuated Vaccine in Chimpanzees
The radiation-attenuated Schistosoma mansoni vaccine is highly effective in rodents and primates but has never been tested in humans, primarily for safety reasons. To strengthen its status as a paradi
PubMed Central20
RNAseq from nasopharyngeal swab RNA prior to intranasal live attenuated influenza vaccine in children
The goal of this study was to identify pre-challenge transcriptomic signatures associated with viral replication of LAIV strains in the nasopharynx. Open label cohort study. clinicaltrials.gov entry f
NIAID Data Ecosystem30
DNA Vaccine Encoding the Chimeric Form of Schistosoma mansoni Sm-TSP2 and Sm29 Confers Partial Protection against Challenge Infection
Schistosomiasis is an important parasitic disease worldwide that affects more than 207 million people in 76 countries and causes approximately 250,000 deaths per year. The best long-term strategy to c
Figshare2016-01-15 更新30
